Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02429466
Title Study of the Hypomethylating Drug SGI-110 Plus Cisplatin in Relapsed Refractory Germ Cell Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Costantine Albany
Indications

germ cell cancer

Therapies

Cisplatin

Guadecitabine

Age Groups: adult
Covered Countries USA


No variant requirements are available.